There's a geek-blog site I check out periodically. It mostly writes about science fiction and popular culture, but occasionally it takes an interesting look at real developments in the sciences and medicine.
Most Recent Posts
You should check-out the piece by Ken Thorpe that recently ran in U.S. News & World Report's Health section. The piece is entitled: Health Reform That Passes the Buck Is Short-Sighted.
David Brooks has a typically thoughtful column in today's New York Times. Brooks takes a look at the roll of healthcare costs in our budget debate and opines:
When discussing progress associated with medical innovation, we like to mention both life-saving and life-enhancing medicines. Why? Because so many debilitating chronic conditions may not be life-threatening, but the patients who live with them still deserve the best that healthcare has to offer.
Monday, we discussed how policies that undercut the biopharmaceutical research sector could lead to huge job losses, with an annual reduction in sector revenue of $20 billion potentially leading to as many as 260,000 lost jobs.
It's no secret that the biopharmaceutical sector provides jobs - and a wide range of jobs, at that. We're not just researchers in lab coats. In terms of jobs we support, we're also the drivers of trucks that help medicines reach pharmacies, the construction workers and technicians who help construct the facilities and equipment necessary for manufacture of medicines, and more. Ultimately, it's an intricate web of workers that all play a role in the important work that we do.
A recent editorial in the New York Times delved into some overarching issues around coverage of cancer medicine. While the paper raises some interesting questions, it unfortunately missed a few key considerations in trying to come up with answers.